CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 1,345	$ 911
Cost of revenue	(612)	(469)
Gross profit	733	442
Selling, general and administrative expenses	(6,758)	(8,552)
Research and development expenses	(3,773)	(3,461)
Operating loss	(9,798)	(11,571)
Impairment loss on PPE	(3,345)	0
Other income, net	143	65
Loss before income taxes	(13,000)	(11,506)
Income tax expense/benefit	0	0
Net loss attributable to common stockholders	(13,000)	(11,506)
Foreign currency translation adjustments	(34)	(421)
Comprehensive loss	$ (13,034)	$ (11,927)
Net loss per share attributable to common stockholders:
Basic and diluted (in Dollars per share)	$ (0.22)	$ (0.22)
Weighted-average number of shares used in computing loss per share amounts: (in Shares)	58,839,868	52,576,258